Frontiers in Cell and Developmental Biology

Review

Published on 13 Feb 2026

Obstructive sleep apnea and lung cancer: molecular underpinnings and clinical translational prospects

in Cancer Cell Biology

Lin Zhang
Fengling Liu
Junyao Li

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2026.1764594

153 views

Review

Published on 13 Feb 2026

BCAAs and related metabolic enzymes: partners in crime driving tumor development

in Cancer Cell Biology

Binfan He
Lingxi Li
Ye Liu
Mengmeng Hao
Ling Zhang
Rongzhang He

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2026.1748587

126 views

Review

Accepted on 12 Feb 2026

PI3K/Akt/mTOR signaling as a novel modulator of ABC transporters: Cutting-Edge Approaches to Mitigate Cancer Drug Resistance

in Cancer Cell Biology

Xiaonuo Jia
Donghui Kong
Tinglan Jin
Xiangyu Zhu
Jinghui Bai

Frontiers in Cell and Developmental Biology

Review

Accepted on 12 Feb 2026

The Neural Niche in Cancer: Mechanistic Insights into Tumor–Neuron–Immune Crosstalk and Therapeutic Opportunities

in Cancer Cell Biology

Hasan Korkaya
Nese Ayşit
Esra Altintas
Fulya Koksalar Alkan
Gurkan Ozturk

Frontiers in Cell and Developmental Biology

Review

Published on 11 Feb 2026

Senescence-associated and immune-related 9p21.3 locus genes in colorectal cancer: epigenetic architecture, molecular landscape and therapeutic possibilities

in Cancer Cell Biology

Darya A. Lisitsa
Vadim V. Shindyapin
Artem R. Nurislamov
Oleg N. Demidov
Daria A. Bogdanova

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2026.1741704

391 views

Review

Accepted on 09 Feb 2026

The Role of Gut Microbiota and its metabolites in Preventing Oncogenesis

in Cancer Cell Biology

Zehua Li
Jiaxi Yan
Ziyi Zeng
Linyong Zhao

Frontiers in Cell and Developmental Biology

Original Research

Accepted on 06 Feb 2026

Development and Clinical Validation of a Nursing Risk Prediction Model for Chemotherapy-Induced Febrile Neutropenia in Patients with Cancer

in Cancer Cell Biology

Fang Xie
Dongmei Zheng
Na Chen
Jie Zhang
Nan Wang
Qin Yi
Lihuai Wang

Frontiers in Cell and Developmental Biology

128 views

Review

Accepted on 06 Feb 2026

H19 and IGF2 Imprinting from Embryogenesis to Oncogenesis

in Cancer Cell Biology

Bella Ortega*
Rida Saeed*
Sloan White*
Patrick Tajanlangit*
G. Ian Gallicano

Frontiers in Cell and Developmental Biology

406 views

Original Research

Accepted on 05 Feb 2026

A novel kinase inhibitor, Regorafenib, blocks EGFR-dependent signaling to repress tumour metastasis in human triple-negative breast cancers

in Cancer Cell Biology

Ying Liu
Ludong Zhao
Chunxin Wang
Yanzhi Wang
Meijing Liu
Hongyu Du
Xiaohui Chu
Wenqiang Yang
Guan Wang
Bo Zhang

Frontiers in Cell and Developmental Biology

169 views

Review

Published on 05 Feb 2026

WWC proteins as emerging biomarkers and therapeutic targets in cancer pathogenesis

in Cancer Cell Biology

Shuge Wang
Junzhe Li
Xianhua Xu
Shijie Xu

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2026.1712319

394 views

Original Research

Published on 05 Feb 2026

Differential responses to the combination of navitoclax and venetoclax with doxorubicin in murine models of triple negative breast cancer

in Cancer Cell Biology

Homood M. As Sobeai
Abdulrahman M. Alanazi
Faisal Alotaibi
Ali Alhoshani
Khalid Alhazzani
Mashal M. Almutairi
Sultan Almudimeegh
Basel K. Al-Ramadi
Eesha Chakraborty
Tareq Saleh

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2026.1661424

663 views

Original Research

Accepted on 04 Feb 2026

Tumour suppressors LKB1 and SMARCA4 functionally interact to regulate gene expression of diverse biological processes in lung cancer

in Cancer Cell Biology

Mohammed Bourouh
Jinhong Kim
Paola A Marignani

Frontiers in Cell and Developmental Biology

116 views

Review

Published on 04 Feb 2026

Branched-chain amino acid transaminases as promising targets in tumor therapy

in Cancer Cell Biology

Weiran Zhang
Jie Shen
Xuanyin Ding
Hele Liu
Xu Wang
Dan Feng

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2026.1712076

383 views

Editorial

Published on 04 Feb 2026

Editorial: Application of novel biomarkers and natural compounds in precision oncology

in Cancer Cell Biology

Yuqing Li
Meng Zhang
Zhao Yang

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2026.1783190

369 views

Original Research

Accepted on 02 Feb 2026

FAM-related prognostic molecular subtypes screening identified epithelial-derived MAOA inhibiting bladder cancer

in Cancer Cell Biology

Hui Yu
雷庆强雷庆强
Wenyong Yang
Min Cao
Miaoyu Zhang
Taisong Wang
Junhao Dong
Xuerui Chen
Xu Su
Yi Huang

Frontiers in Cell and Developmental Biology

131 views

Original Research

Accepted on 02 Feb 2026

Machine Learning-Derived AS and AIS Scores Leverage BCAA Metabolism and IL4I1 Activity for Prognosis and Tailored Therapy in ccRCC

in Cancer Cell Biology

Kang qiang weng
Xin Li
Xiaobao Chen
Junwei Lin
ling jun Liu
Le ye Yan
Ruo yun Xie

Frontiers in Cell and Developmental Biology

109 views

Original Research

Accepted on 02 Feb 2026

Remics: A Redescription-based Framework for Multi-Omics Analysis

in Cancer Cell Biology

Aritra Bose
Daniel E. Platt
Kahn Rhrissorrakrai
Myson Burch
Aldo Guzmán Sáenz
Niina Haiminen
Laxmi Parida

Frontiers in Cell and Developmental Biology

110 views

Review

Published on 02 Feb 2026

Unveiling the tumor microenvironment in colorectal cancer therapeutic resistance

in Cancer Cell Biology

Jiyu Han
Weitian Liang
Kai Li

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2025.1753180

402 views

Original Research

Accepted on 31 Jan 2026

AC005034.3/hsa-miR-126-5p/EIF3H Axis: Bioinformatics Analysis, Expression Validation, and Association with Prognosis and Immunosuppressive Microenvironment in Pancreatic Adenocarcinoma

in Cancer Cell Biology

Kai Sun
Zhi-xin Song
Xiao-yun Zhang
Xuexing Wang
Song Wen
Ke-run Wang
Yi-lian Qiu

Frontiers in Cell and Developmental Biology

137 views

Original Research

Accepted on 29 Jan 2026

Single-cell Atlas Reveals a Pro-metastatic RELB+ Neutrophil-Myeloid Subset Underlying Lymph Node Metastasis in EGFR-wildtype LUAD

in Cancer Cell Biology

Fasheng Li
Xiao Yang
Ang Li
Yutao Pang
Hongfei Zhang
Liyao Lin
Dong Wu

Frontiers in Cell and Developmental Biology

131 views

Review

Accepted on 29 Jan 2026

Unlocking the Undruggable Spliceosome: Generative AI and Structural Dynamics in Cancer Therapy

in Cancer Cell Biology

Jakob Steuer
Abdullah Kahraman

Frontiers in Cell and Developmental Biology

163 views

Original Research

Published on 29 Jan 2026

STC2 promotes anoikis resistance by modulating TGIF1 mRNA stability in colorectal cancer

in Cancer Cell Biology

Fan Hu
Qiuming He
Zheyu Ding
Jie Cheng
Jun Lin

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2025.1695361

543 views

Review

Published on 29 Jan 2026

Gastric cancer organoids: a promising model for personalized treatment of gastric cancer

in Cancer Cell Biology

Yu Chang
Yu Liu
Huahua Zhang
Xia Lei
Yunfeng Hu

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2025.1712621

654 views

Original Research

Published on 27 Jan 2026

Breast cancer bone metastasis and bone metastatic cells retain NKG2DLs intracellularly: could this be a strategy to evade immune recognition?

in Cancer Cell Biology

Marta Gomarasca
Paola Maroni
Chiara Verdelli
Laura Gerosa
Martina Faraldi
Alessandro Luzzati
Luca Cannavò
Giuseppe Banfi
Giovanni Lombardi

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2026.1717607

661 views

788 articles

articles

Obstructive sleep apnea and lung cancer: molecular underpinnings and clinical translational prospects

BCAAs and related metabolic enzymes: partners in crime driving tumor development

PI3K/Akt/mTOR signaling as a novel modulator of ABC transporters: Cutting-Edge Approaches to Mitigate Cancer Drug Resistance

The Neural Niche in Cancer: Mechanistic Insights into Tumor–Neuron–Immune Crosstalk and Therapeutic Opportunities

Senescence-associated and immune-related 9p21.3 locus genes in colorectal cancer: epigenetic architecture, molecular landscape and therapeutic possibilities

The Role of Gut Microbiota and its metabolites in Preventing Oncogenesis

Development and Clinical Validation of a Nursing Risk Prediction Model for Chemotherapy-Induced Febrile Neutropenia in Patients with Cancer

H19 and IGF2 Imprinting from Embryogenesis to Oncogenesis

A novel kinase inhibitor, Regorafenib, blocks EGFR-dependent signaling to repress tumour metastasis in human triple-negative breast cancers

WWC proteins as emerging biomarkers and therapeutic targets in cancer pathogenesis

Differential responses to the combination of navitoclax and venetoclax with doxorubicin in murine models of triple negative breast cancer

Tumour suppressors LKB1 and SMARCA4 functionally interact to regulate gene expression of diverse biological processes in lung cancer

Branched-chain amino acid transaminases as promising targets in tumor therapy

Editorial: Application of novel biomarkers and natural compounds in precision oncology

FAM-related prognostic molecular subtypes screening identified epithelial-derived MAOA inhibiting bladder cancer

Machine Learning-Derived AS and AIS Scores Leverage BCAA Metabolism and IL4I1 Activity for Prognosis and Tailored Therapy in ccRCC

Remics: A Redescription-based Framework for Multi-Omics Analysis

Unveiling the tumor microenvironment in colorectal cancer therapeutic resistance

AC005034.3/hsa-miR-126-5p/EIF3H Axis: Bioinformatics Analysis, Expression Validation, and Association with Prognosis and Immunosuppressive Microenvironment in Pancreatic Adenocarcinoma

Single-cell Atlas Reveals a Pro-metastatic RELB+ Neutrophil-Myeloid Subset Underlying Lymph Node Metastasis in EGFR-wildtype LUAD

Unlocking the Undruggable Spliceosome: Generative AI and Structural Dynamics in Cancer Therapy

STC2 promotes anoikis resistance by modulating TGIF1 mRNA stability in colorectal cancer

Gastric cancer organoids: a promising model for personalized treatment of gastric cancer

Breast cancer bone metastasis and bone metastatic cells retain NKG2DLs intracellularly: could this be a strategy to evade immune recognition?